One anastomosis gastric bypass as a primary bariatric surgery: MBSAQIP database analysis of short-term safety and outcomes
- 21 November 2023
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 38 (1) , 270-279
Abstract
Background One anastomosis gastric bypass (OAGB) is described as a simpler, potentially safe, and effective bariatric-metabolic procedure that has been recently endorsed by the American Society of Metabolic and Bariatric Surgery. Objectives First, we aim to compare the 30-day outcomes between OAGB and other bypass procedures: Roux-en-Y gastric bypass (RYGB) and single anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S). Second, identify the odds between postoperative complications and each surgical procedure. Methods Patients who underwent primary OAGB, RYGB, and SADI-S were identified using the MBSAQIP database of 2020 and 2021. An analysis of patient demographics and 30-day outcomes were compared between these three bypass procedures. In addition, a multilogistic regression for overall complications, blood transfusions, unplanned ICU admissions, readmission, reoperation, and anastomotic leak stratified by surgical procedure was performed. Results 1607 primary OAGBs were reported between 2020 and 2021. In terms of patient demographics, patients who underwent RYGB and SADI-S showed a higher incidence of comorbidities. On the other hand, OAGB had shorter length of stay (1.39 ± 1.10 days vs 1.62 ± 1.42 days and 1.90 ± 2.04 days) and operative times (98.79 ± 52.76 min vs 125.91 ± 57.76 min and 139.85 ± 59.20 min) than RYGB and SADI-S. Similarly, OAGB showed lower rates of overall complications (1.9% vs 4.5% and 6.4%), blood transfusions (0.4% vs 1.1% and 1.8%), unplanned ICU admission (0.3% vs 0.8% and 1.4%), readmission (2.4% vs 4.9% and 5.0%), and reoperation (1.2% vs 1.9% and 3.1%). A multilogistic regression analysis was performed, RYGB and SADI-S demonstrated higher odds of 30-day complications. Conclusion The incidence of primary OAGB has increased since its approval by ASMBS, from 0.05% reported between 2015 and 2019 to 0.78% between 2020 and 2021. OAGB had better 30-day outcomes and shorter operative times than RYGB and SADI-S and therefore, could be considered a viable alternative.Keywords
This publication has 43 references indexed in Scilit:
- A 7-Year Clinical Audit of 1107 Cases Comparing Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and Mini-Gastric Bypass, to Determine an Effective and Safe Bariatric and Metabolic ProcedureObesity Surgery, 2015
- One Thousand Single Anastomosis (Omega Loop) Gastric Bypasses to Treat Morbid Obesity in a 7-Year Period: Outcomes Show Few Complications and Good EfficacyObesity Surgery, 2015
- Single-Anastomosis Gastric Bypass (SAGB): Appraisal of Clinical EvidenceObesity Surgery, 2014
- A 6-Year Experience with 1,054 Mini-Gastric Bypasses—First Study from Indian SubcontinentObesity Surgery, 2014
- Bariatric Surgery to Treat ObesitySeminars in Nephrology, 2013
- One Thousand Consecutive Mini-Gastric Bypass: Short- and Long-term OutcomeObesity Surgery, 2012
- Continued Excellent Results with the Mini-Gastric Bypass: Six-Year Study in 2,410 PatientsObesity Surgery, 2005
- Laparoscopic Roux-en-Y Versus Mini-Gastric Bypass for the Treatment of Morbid ObesityAnnals of Surgery, 2005
- One-Anastomosis Gastric Bypass by Laparoscopy: Results of the First 209 PatientsObesity Surgery, 2005
- The Mini-Gastric Bypass: Experience with the First 1,274 CasesObesity Surgery, 2001